Sign in

CIK 0001061983 · Large accelerated filer

CYTOKINETICS INC

Sign in to watch
Ticker
CYTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
943291317
Phone
(650) 624-3000
Business address
350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Planned sale EVP Research & Development sold 3,500 shares at $79.51 ($278,285)
  2. 4 Planned sale President & CEO sold 7,500 shares at $70.46 ($528,450)
  3. 4 Planned sale EVP Research & Development sold 3,500 shares at $67.98 ($237,930)
  4. 4 Planned sale Director sold 2,933 shares at $76.09 ($223,172)
  5. 4 Planned sale EVP, Chief Commercial Officer sold 15,000 shares at $74.08 ($1,111,200)
  6. 4 Planned sale Director sold 5,000 shares at $74.08 ($370,400)
  7. 144 Insider Sale of Securities
  8. 4 Planned sale President & CEO sold 7,500 shares at $77.21 ($579,075)
  9. 4 Grant or award Director acquired 2,851 shares (grant or award)
  10. 4 Grant or award Director acquired 2,851 shares (grant or award)
  11. 4 Grant or award Director acquired 2,851 shares (grant or award)
  12. 4 Grant or award Director acquired 2,851 shares (grant or award)
  13. 4 Grant or award Director acquired 2,851 shares (grant or award)
  14. 4 Grant or award Director acquired 2,851 shares (grant or award)
  15. 4 Grant or award Director acquired 2,851 shares (grant or award)
  16. 4 Grant or award Director acquired 2,851 shares (grant or award)
  17. 4 Grant or award Director acquired 2,851 shares (grant or award)
  18. S-8 Other Securities Offered to Employees in Benefit Plans
  19. 8-K Event Shareholder vote results
  20. 4 Planned sale EVP Research & Development sold 3,500 shares at $75.69 ($264,915)

Page 4 of 127 · 2,534 filings